Local variation in low carbon footprint inhalers in pre-COVID pandemic primary care prescribing guidelines for adult asthma in England and its potential impact.
Journal Information
Full Title: Br J Clin Pharmacol
Abbreviation: Br J Clin Pharmacol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"COMPETING INTEREST A.T. has no competing interests. A.W. is a member of the UN Medical and Chemical Technical Options Committee, the NHSE/I inhaler experts working group, and has made unpaid contributions to research on the carbon footprint of inhalers which was funded by AstraZeneca and GlaxoSmithKline. J.S. is married to a general practitioner who is a partner in a dispensing practice in Cambridgeshire."
"We would like to acknowledge Dr Mary Fortune, Department of Public Health and Primary Care, who advised on statistical methods. There was no funding received for this work."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025